Eli Lilly & Co. LLY said Friday a late-stage trial of a treatment for a type of non-small cell lung…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pharmawerte lagen die letzten Monate über eigentlich recht gut im Rennen und Titel wie Eli Lilly oder Vertex Pharmaceuticals führten…
The data bolsters Eli Lillys position in the budding weight loss drug market and establishes the company as a formidable…
Thursdays top analyst upgrades and downgrades included Alphabet, Eli Lilly, Etsy, Microsoft, Mosaic, NetApp, Omega Healthcare Investors, RTX, Sherwin-Williams, Spotify…
Pharma - Der US-Pharmakonzern Eli Lilly sieht die Wirksamkeit seines neuen Abnehmmedikaments Tirzepatide durch zwei entscheidende Studien bestätigt....…
The drugmaker may be running out of steam....…
INDIANAPOLIS, July 25, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2023 financial results on…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
INDIANAPOLIS (dpa-AFX) - Drug manufacturer Eli Lilly and Co. (LLY) Tuesday announced the extension of its tender offer to acquire…
INDIANAPOLIS, July 25, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of…
Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-07-21...…
Investoren stürzen sich auf die Pharmaunternehmen, denen sie am meisten Wachstum zutrauen. Solche finden sie zurzeit nicht in der Schweiz....…
In trials, Biogen and Eli Lilly have shown that their drugs can slow early-stage decline in the disease. It could…
Morgan Stanley now projects the global obesity market will reach $77 billion in 2030, with bullish implications for Club name…
In the latest trading session, Eli Lilly (LLY) closed at $451.20, marking a +0.91% move from the previous day....…
Eli Lilly and Co. LLY and Biogen Inc. BIIB are likely to reach an “equitable split” of the Alzheimer’s drug…
Shares of the pharmaceutical giant are already up 36% this year....…
Auf der Suche nach einem Medikament gegen Alzheimer konnte der US-Pharmakonzern Eli Lilly einen Durchbruch bei Patienten im Frühstadium erzielen.…
A Phase 3 trial shows that Eli Lilly's investigational Alzheimer’s treatment donanemab significantly slowed cognitive and functional decline in people in…
For the purchase of Versanis, Lilly (LLY) agrees to pay up to $1.93 billion in cash....…
Eli Lilly is racing to market donanemab for Alzheimers after Eisai and Biogens drug for the disease, Leqembi, won FDA…
Eli Lilly Alzheimer's Treatment Donanemab Seen Slowing Cognitive, Functional Decline...…
Frankfurt (Reuters) - Das neue Alzheimer-Medikament des US-Pharmakonzerns Eli Lilly wirkt im Frühstadium der Krankheit offenbar besser als gedacht.
Bei…
Mondays top analyst upgrades and downgrades included Amazon.com, AT&T, Broadcom, Corning, DraftKings, Eli Lilly, Fortinet, General Mills, Leslies, Microsoft, Nvidia,…
Can the company maintain the momentum its had in recent years?...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
An acquisition in the lucrative weight loss market is sparking a rally in the drugmakers shares today....…
The deal is Eli Lillys latest attempt to capitalize on the weight loss industry gold rush, which was sparked by…
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could…
Von Ben Glickman NEW YORK (Dow Jones)--Der US-Pharmakonzern Eli Lilly will Versanis Bio für bis zu 1,93 Milliarden US-Dollar…
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) and Versanis Bio announced a definitive agreement for Lilly to acquire Versanis,…
...(Adds deal terms in paragraph 2)
July 14 (Reuters) - Eli Lilly and Co......…
...(Reuters) - Eli Lilly and Co said on Friday it will acquire......…
Eli Lilly and Co. LLY will acquire Versanis Bio, a private clinical-stage biopharma company focused on new treatments for cardiometabolic…
INDIANAPOLIS and NEW YORK, July 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Versanis Bio today announced…
Warren said the report shows that Congress needs to take additional steps to reduce the excessive prices of insulin from…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), UnitedHealth Group Incorporated (UNH) and…
The European Medicines Agency didnt specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli…
BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, ein Marktführer für technische Lösungen und Dienstleistungen für die Biotechnologie-Produktion hat angekündigt, dass er mehrere Custom Single…
This drugmaker is a compelling dividend growth play....…
Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-06-30...…
Clinical data suggests that a powerful candidate is advancing through its pipeline....…
Lilly has a drug in testing that sets a new standard for weight loss, and another behind it that could…
Lilly Endowment Inc - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-06-29...…
read more...…